HAEMOPHILIA A WITH INHIBITORS
Clinical trials for HAEMOPHILIA A WITH INHIBITORS explained in plain language.
Never miss a new study
Get alerted when new HAEMOPHILIA A WITH INHIBITORS trials appear
Sign up with your email to follow new studies for HAEMOPHILIA A WITH INHIBITORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot could cut bleeding episodes for hemophilia a patients
Disease control CompletedThis study tested a new medicine called Mim8 in 281 adults and teens with hemophilia A, including those whose bodies make antibodies that block standard treatment. Mim8 helps replace the missing clotting factor and is given as a weekly or monthly injection under the skin. The goa…
Matched conditions: HAEMOPHILIA A WITH INHIBITORS
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New shot Mim8 shows promise for hemophilia a bleed control
Disease control CompletedThis study looked at how safe it is for people with hemophilia A to switch from their current medicine (emicizumab) to a new one called Mim8. Mim8 helps prevent bleeding episodes by doing the job of the missing clotting factor. The study included 61 adults and teens who received …
Matched conditions: HAEMOPHILIA A WITH INHIBITORS
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC